Medical cannabis trial will target 20,000 UK patients

Medical, Compliance | John Doe | 17 January 2020

Project backed by Royal College of Psychiatrists aims to be largest on drug’s use in Europe

Up to 20,000 patients in the UK are to be given medical cannabis over a two-year period in an initiative that aims to create the largest body of evidence on the drug in Europe.

The move, to be unveiled on Thursday, is backed by one of the UK’s leading medical bodies and it is hoped it will persuade the NHS to prescribe the drug for a range of conditions.

Although medical cannabis was legalised in the UK a year ago, it remains unobtainable for many patients, according to campaigners.

Continue reading...

This website uses cookies!

Cookies are important to maintain the functionality of this website and to continually improve your experience.
We'll assume you're okay with this unless you decide to opt out — Find out more